• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DKI 可区分高级别胶质瘤和 IDH1 突变型低级别胶质瘤,并与其不同的核浆比相关:一项基于局部活检的研究。

DKI can distinguish high-grade gliomas from IDH1-mutant low-grade gliomas and correlate with their different nuclear-to-cytoplasm ratio: a localized biopsy-based study.

机构信息

Department of Integrative Oncology, Fudan University Shanghai Cancer Center, #270 DongAn Road, Shanghai, 200032, People's Republic of China.

Department of Oncology, Shanghai Medical College, Fudan University, #270 DongAn Road, Shanghai, 200032, People's Republic of China.

出版信息

Eur Radiol. 2024 Nov;34(11):7539-7551. doi: 10.1007/s00330-023-10325-8. Epub 2023 Nov 14.

DOI:10.1007/s00330-023-10325-8
PMID:37962597
Abstract

OBJECTIVES

To explore whether differences in diffusional kurtosis imaging (DKI) between therapy-naïve high-grade gliomas (HGGs) and low-grade gliomas (LGGs) are related to the cellularity and/or the nuclear-to-cytoplasmic (N/C) ratio.

METHODS

We analyzed 44 and 40 diffuse glioma samples that were pathologically confirmed as HGGs and IDH1-mutant LGGs, respectively. The DKI parameters included kurtosis metrics (mean kurtosis [MK], axial kurtosis [K], and radial kurtosis [K]), and the diffusional metrics (fractional anisotropy [FA], mean diffusion [MD], axial diffusion [λ], and radial diffusion [λ]). The cellularity and the N/C ratio were compared within LGGs and HGGs using the Mann-Whitney U test (significant level, p < 0.007 [0.05/7]); Bonferroni correction). Spearman's correlation analysis was used to calculate the correlation coefficients among DKI metrics, cellularity, and the N/C ratio at a significant level of p = 0.05.

RESULTS

Excluding FA, all DKI metrics showed significant differences between HGGs and LGGs (all p ≤ 0.001). The N/C ratio of HGGs was significantly higher than that of LGGs; however, differences in cellularity were not significant between the two glioma groups (p = 0.525). Similarly, excluding FA, all DKI metrics were significantly correlated with the N/C ratio in LGGs, with correlation coefficients of - 0.365 (MD), - 0.313 (λ), - 0.376 (λ), 0.859 (MK), 0.772 (K), and 0.842 (K). There was a non-significant correlation between any DKI parameters and the cellularity in LGGs. Additionally, the cellularity and N/C ratios in HGGs did not correlate with any DKI metrics.

CONCLUSIONS

DKI differentiate LGGs from HGGs associated with their different N/C ratios.

CLINICAL RELEVANCE STATEMENT

This study shows that DKI differentiates LGGs from HGGs may correlated with their different N/C ratios, this could provide a possible histopathological mechanism about why DKI can DKI differentiate LGGs from HGGs.

KEY POINTS

• Excluding FA, all DKI metrics showed a significant difference between high-grade gliomas and IDH1-mutant low-grade gliomas. • The nuclear-to-cytoplasm ratios in high-grade gliomas were significantly more extensive than that in IDH1-mutant low-grade gliomas, but not the cellularity. • Significant associations were seen between DKI measures and the N/C ratio; a non-significant correlation was noted between any DKI metric and cellularity in glioma specimens.

摘要

目的

探讨治疗前高级别胶质瘤(HGG)和低级别胶质瘤(LGG)之间弥散峰度成像(DKI)的差异是否与细胞密度和/或核质比(N/C 比)有关。

方法

我们分析了 44 例经病理证实为 HGG 和 40 例 IDH1 突变型 LGG 的弥漫性胶质瘤样本。DKI 参数包括峰度度量(平均峰度[MK]、轴向峰度[K]和径向峰度[K])和弥散度量(各向异性分数[FA]、平均弥散[MD]、轴向弥散[λ]和径向弥散[λ])。使用 Mann-Whitney U 检验(显著水平,p < 0.007[0.05/7];Bonferroni 校正)比较 LGG 和 HGG 内的细胞密度和 N/C 比。使用 Spearman 相关分析在显著水平 p = 0.05 计算 DKI 指标、细胞密度和 N/C 比之间的相关系数。

结果

除 FA 外,所有 DKI 指标在 HGG 和 LGG 之间均有显著差异(均 p≤0.001)。HGG 的 N/C 比值明显高于 LGG;然而,两组胶质瘤之间的细胞密度差异无统计学意义(p=0.525)。同样,除 FA 外,所有 DKI 指标与 LGG 中的 N/C 比均有显著相关性,相关系数分别为-0.365(MD)、-0.313(λ)、-0.376(λ)、0.859(MK)、0.772(K)和 0.842(K)。LGG 中,任何 DKI 参数与细胞密度之间均无显著相关性。此外,HGG 中的细胞密度和 N/C 比值与任何 DKI 参数均无相关性。

结论

DKI 可区分 LGG 和 HGG,与它们的不同 N/C 比值有关。

临床相关性声明

本研究表明,DKI 可区分 LGG 和 HGG,这可能与它们的不同 N/C 比值有关,这可能为 DKI 为何能区分 LGG 和 HGG 提供一种可能的组织病理学机制。

要点

• 除 FA 外,高级别胶质瘤和 IDH1 突变型低级别胶质瘤之间的所有 DKI 指标均有显著差异。• 高级别胶质瘤的核质比明显大于 IDH1 突变型低级别胶质瘤,但细胞密度无差异。• DKI 指标与 N/C 比之间存在显著相关性;在胶质瘤标本中,任何 DKI 指标与细胞密度之间的相关性均不显著。

相似文献

1
DKI can distinguish high-grade gliomas from IDH1-mutant low-grade gliomas and correlate with their different nuclear-to-cytoplasm ratio: a localized biopsy-based study.DKI 可区分高级别胶质瘤和 IDH1 突变型低级别胶质瘤,并与其不同的核浆比相关:一项基于局部活检的研究。
Eur Radiol. 2024 Nov;34(11):7539-7551. doi: 10.1007/s00330-023-10325-8. Epub 2023 Nov 14.
2
Diffusion kurtosis imaging differs between primary central nervous system lymphoma and high-grade glioma and is correlated with the diverse nuclear-to-cytoplasmic ratio: a histopathologic, biopsy-based study.弥散峰度成像在原发性中枢神经系统淋巴瘤和高级别胶质瘤之间存在差异,并且与不同的核浆比相关:一项基于组织病理学和活检的研究。
Eur Radiol. 2020 Apr;30(4):2125-2137. doi: 10.1007/s00330-019-06544-7. Epub 2019 Dec 19.
3
Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.对比分析扩散峰度成像和扩散张量成像在胶质瘤分级、预测肿瘤细胞增殖和 IDH-1 基因突变状态中的作用。
J Neurooncol. 2019 Jan;141(1):195-203. doi: 10.1007/s11060-018-03025-7. Epub 2018 Nov 9.
4
Diffusional kurtosis imaging for differentiating between high-grade glioma and primary central nervous system lymphoma.扩散峰度成像用于鉴别高级别胶质瘤和原发性中枢神经系统淋巴瘤。
J Magn Reson Imaging. 2016 Jul;44(1):30-40. doi: 10.1002/jmri.25090. Epub 2015 Nov 20.
5
Histogram analysis of diffusion kurtosis imaging derived maps may distinguish between low and high grade gliomas before surgery.基于扩散峰度成像衍生图的直方图分析可在术前区分低级别和高级别胶质瘤。
Eur Radiol. 2018 Apr;28(4):1748-1755. doi: 10.1007/s00330-017-5108-1. Epub 2017 Nov 16.
6
Evaluation of histopathological changes in the microstructure at the center and periphery of glioma tumors using diffusional kurtosis imaging.使用扩散峰度成像评估胶质瘤肿瘤中心和周边微观结构的组织病理学变化。
Clin Neurol Neurosurg. 2016 Dec;151:120-127. doi: 10.1016/j.clineuro.2016.10.018. Epub 2016 Oct 27.
7
Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.通过酰胺质子转移磁共振成像对无强化的弥漫性胶质瘤进行分级:与扩散加权成像和灌注加权成像的比较
Eur Radiol. 2017 Feb;27(2):578-588. doi: 10.1007/s00330-016-4328-0. Epub 2016 Mar 22.
8
Mean apparent propagator-MRI in evaluation of glioma grade, cellular proliferation, and IDH-1 gene mutation status.表观扩散系数-MRI 均值在评价胶质瘤分级、细胞增殖及 IDH1 基因突变状态中的作用。
Eur Radiol. 2022 Jun;32(6):3744-3754. doi: 10.1007/s00330-021-08522-4. Epub 2022 Jan 25.
9
Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging.使用 MR 扩散方差分解(DIVIDE)成像对神经胶质瘤进行分级、分子特征分类和微观结构特征描述。
Eur Radiol. 2021 Nov;31(11):8197-8207. doi: 10.1007/s00330-021-07959-x. Epub 2021 Apr 29.
10
Noninvasively evaluating the grade and IDH mutation status of gliomas by using mono-exponential, bi-exponential diffusion-weighted imaging and three-dimensional pseudo-continuous arterial spin labeling.通过单指数、双指数扩散加权成像和三维准连续动脉自旋标记技术无创评估脑胶质瘤的分级和 IDH 突变状态。
Eur J Radiol. 2023 Mar;160:110721. doi: 10.1016/j.ejrad.2023.110721. Epub 2023 Feb 1.

引用本文的文献

1
Non-Invasive Diagnosis and Monitoring of Diabetic Nephropathy: Assessment of Renal Function and Fibrosis by Diffusion Kurtosis Imaging.糖尿病肾病的非侵入性诊断与监测:通过扩散峰度成像评估肾功能和纤维化
Int J Gen Med. 2025 Jul 21;18:4011-4026. doi: 10.2147/IJGM.S517683. eCollection 2025.
2
The diagnostic and prediction performance of MR diffusion kurtosis imaging in the glioma molecular classification: a systematic review and meta-analysis.磁共振扩散峰度成像在胶质瘤分子分类中的诊断及预测性能:一项系统评价与Meta分析
Front Neurol. 2025 Apr 25;16:1543619. doi: 10.3389/fneur.2025.1543619. eCollection 2025.
3
The value of morphological magnetic resonance imaging features combined with diffusion kurtosis imaging for predicting Ki-67 expression levels in high-grade gliomas.

本文引用的文献

1
The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications.《2021年世界卫生组织中枢神经系统肿瘤分类:临床意义》
Neuro Oncol. 2021 Aug 2;23(8):1215-1217. doi: 10.1093/neuonc/noab120.
2
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
3
High-Resolution Diffusion-Weighted Imaging of C6 Glioma on a 7T BioSpec MRI Scanner: Correlation of Tumor Cellularity and Nuclear-to-Cytoplasmic Ratio with Apparent Diffusion Coefficient.
形态学磁共振成像特征联合扩散峰度成像预测高级别胶质瘤中Ki-67表达水平的价值
Quant Imaging Med Surg. 2025 Apr 1;15(4):2813-2826. doi: 10.21037/qims-24-2035. Epub 2025 Mar 21.
4
Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment: a prospective study of clinical functional MR-based modeling.通过早期反应评估和方案调整改善结直肠癌肝转移的治疗:基于临床功能磁共振成像建模的前瞻性研究
Cancer Biol Med. 2025 Feb 21;22(2):166-76. doi: 10.20892/j.issn.2095-3941.2024.0389.
5
Research Progress on Glioma Microenvironment and Invasiveness Utilizing Advanced Multi-Parametric Quantitative MRI.利用先进的多参数定量磁共振成像对胶质瘤微环境与侵袭性的研究进展
Cancers (Basel). 2024 Dec 29;17(1):74. doi: 10.3390/cancers17010074.
6
Diffusion kurtosis imaging-based habitat analysis identifies high-risk molecular subtypes and heterogeneity matching in diffuse gliomas.基于扩散峰度成像的栖息地分析鉴定弥漫性 gliomas 中的高风险分子亚型和异质性匹配。
Ann Clin Transl Neurol. 2024 Aug;11(8):2073-2087. doi: 10.1002/acn3.52128. Epub 2024 Jun 18.
7T 生物磁共振扫描仪上 C6 神经胶质瘤的高分辨率弥散加权成像:肿瘤细胞密度与核浆比与表观弥散系数的相关性。
Acad Radiol. 2022 Mar;29 Suppl 3:S80-S87. doi: 10.1016/j.acra.2021.02.009. Epub 2021 Jun 18.
4
Diffusion kurtosis imaging differs between primary central nervous system lymphoma and high-grade glioma and is correlated with the diverse nuclear-to-cytoplasmic ratio: a histopathologic, biopsy-based study.弥散峰度成像在原发性中枢神经系统淋巴瘤和高级别胶质瘤之间存在差异,并且与不同的核浆比相关:一项基于组织病理学和活检的研究。
Eur Radiol. 2020 Apr;30(4):2125-2137. doi: 10.1007/s00330-019-06544-7. Epub 2019 Dec 19.
5
3D-ASL perfusion correlates with VEGF expression and overall survival in glioma patients: Comparison of quantitative perfusion and pathology on accurate spatial location-matched basis.3D-ASL 灌注与胶质瘤患者 VEGF 表达和总生存期相关:基于准确空间位置匹配的定量灌注和病理学比较。
J Magn Reson Imaging. 2019 Jul;50(1):209-220. doi: 10.1002/jmri.26562. Epub 2019 Jan 16.
6
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.CBTRUS统计报告:2010 - 2014年在美国诊断出的原发性脑和其他中枢神经系统肿瘤
Neuro Oncol. 2017 Nov 6;19(suppl_5):v1-v88. doi: 10.1093/neuonc/nox158.
7
Perfusion imaging of brain gliomas using arterial spin labeling: correlation with histopathological vascular density in MRI-guided biopsies.利用动脉自旋标记技术对脑胶质瘤进行灌注成像:与MRI引导活检中组织病理学血管密度的相关性
Neuroradiology. 2017 Jan;59(1):51-59. doi: 10.1007/s00234-016-1756-0. Epub 2016 Dec 6.
8
Comparison of diffusion tensor imaging and C-methionine positron emission tomography for reliable prediction of tumor cell density in gliomas.比较弥散张量成像和 C-蛋氨酸正电子发射断层扫描在胶质瘤中可靠预测肿瘤细胞密度的价值。
J Neurosurg. 2016 Nov;125(5):1136-1142. doi: 10.3171/2015.11.JNS151848. Epub 2016 Feb 26.
9
Diffusional kurtosis imaging for differentiating between high-grade glioma and primary central nervous system lymphoma.扩散峰度成像用于鉴别高级别胶质瘤和原发性中枢神经系统淋巴瘤。
J Magn Reson Imaging. 2016 Jul;44(1):30-40. doi: 10.1002/jmri.25090. Epub 2015 Nov 20.
10
Young investigator challenge: The accuracy of the nuclear-to-cytoplasmic ratio estimation among trained morphologists.青年研究者挑战:训练有素的形态学家对核质比估计的准确性。
Cancer Cytopathol. 2015 Sep;123(9):524-30. doi: 10.1002/cncy.21585.